Detection frequency and duration of circulating antiphospholipid syndrome markers in patients with verified COVID-19

QR Code

Detection frequency and duration of circulating antiphospholipid syndrome markers in patients with verified COVID-19

Aim: to develop enzyme-linked immunosorbent tests for assessing the antiphospholipid syndrome (APS) markers and determine prevalence of three antiphospholipid antibody (aPL) types at different COVID-19 stages. Materials and Methods. A comparative longitudinal controlled study was conducted by exam...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. V. Mikhailova, N. V. Chepurchenko, A. P. Obriadina
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2024-05-01
Series:	Акушерство, гинекология и репродукция
Subjects:	antiphospholipid antibodies apl covid-19 antiphospholipid syndrome aps anti-β2-glycoprotein 1 antibodies аβ2-gp1 anticardiolipin antibodies acl anti-phosphatidylserine-prothrombin complex antibodies aps-pt
Online Access:	https://www.gynecology.su/jour/article/view/2049
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Thrombotic antiphospholipid syndrome: Recurrent thromboses
by: Tatiana M. Reshetnyak, et al.
Published: (2024-09-01)

Antiphospholipid antibodies as a potential factor of tumor progression
by: Z. D. Aslanova, et al.
Published: (2024-03-01)

Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)
by: F. A. Cheldieva, et al.
Published: (2021-10-01)

Plasmapheresis for lowering the risks of placenta-associated complications in antiphospholipid syndrome
by: N. F. Kuneshko, et al.
Published: (2025-03-01)

Antibodies to domain I β2 -glycoprotein 1 in patients with antiphospholipid syndrome and systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-07-01)

Clinical significance of antibodies to the phosphatidylserine/prothrombin complex
by: T. M. Reshetnyak, et al.
Published: (2022-05-01)

Catastrophic antiphospholipid COVID-19 syndrome
by: Yu. S. Polushin, et al.
Published: (2021-03-01)

Assessment of antiphospholipid antibodies using enzyme-linked immunosorbent assay and chemiluminescent method
by: T. M. Reshetnyak, et al.
Published: (2025-04-01)

Detection of antibodies associated with anti-phospholipid syndrome in patients with syphilis
by: N. K. Levchik, et al.
Published: (2023-04-01)

The absence of standardization in antiphospholipid antibody testing may favor the use of 99th percentile cutoffs in antiphospholipid syndrome classification
by: Ariadna Anunciación-Llunell, et al.
Published: (2025-07-01)

Antiphospholipide antibodies subtypes in systemic lupus erythematosus and antiphospholipid syndrome
by: T M Reshetnyak, et al.
Published: (2005-10-01)

Criteria and non-criteria anti-phospholipid antibodies in the different clinical forms of antiphospholipid syndrome
by: Oscar Cabrera-Marante, et al.
Published: (2025-08-01)

Damage Burden in Polish Patients with Antiphospholipid Syndrome Measured Using Damage Index for Antiphospholipid Syndrome (DIAPS)
by: Ewa Haladyj, et al.
Published: (2025-07-01)

THE IX EUROPEAN FORUM ON ANTIPHOSPHOLIPID ANTIBODIES. A BRIEF REVIEW
by: Nataliya V Seredavkina, et al.
Published: (2014-03-01)

Autoantibodies and SARS-CoV-2 infection: A case report
by: T. I. Kalenchic, et al.
Published: (2022-07-01)

A clinical case report: stroke in a young patient with systemic lupus erythematosus on the background of secondary antiphospholipid syndrome
by: S.I. Shkrobot, et al.
Published: (2022-12-01)

ANTIPHOSPHOLIPID ANTIBODIES, THEIR PATHOGENETIC AND DIAGNOSTIC ISSUES OBSTETRIC PRACTICE
by: V. O. Bitsadze, et al.
Published: (2016-06-01)

RECURRENT FETAL LOSS IN THE PRIMARY ANTIPHOSPHOLIPID SYNDROME (CASE REPORT)
by: Z S Alekberova, et al.
Published: (2000-02-01)

Pregnancy and its outcome in antiphospholipid syndrome after acute cerebral circulatory failure (clinical case study)
by: T. M. Reshetnyak, et al.
Published: (2024-06-01)

ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
by: Tat’yana M Reshetnyak
Published: (2014-03-01)

Gestation in patients with a combination of antiphospholipid and torch syndromes
by: E. N. Kravchenko, et al.
Published: (2021-07-01)

USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES
by: M. I. Krivonos, et al.
Published: (2017-12-01)

The role of family anamnesis investigation in antiphospholipid syndrome
by: N. N. Chapayeva, et al.
Published: (2009-04-01)

Prevention of recurrent fetal growth retardation in patients with circulating antiphospholipid antibodies and genetic thrombophilia
by: E. A. Orudzhova, et al.
Published: (2022-05-01)

Direct-acting oral anticoagulants in antiphospholipid syndrome
by: T. M. Reshetnyak, et al.
Published: (2021-01-01)

On the pathogenesis of thromboses in antiphospholipid syndrome
by: T. A. Sukontseva, et al.
Published: (2018-11-01)

Antiphospholipid antibodies, genetic thrombophilia and fetal growth retardation
by: E. A. Orudzhova
Published: (2022-01-01)

Assessing the effectiveness of preventing placenta-associated complications in patients with burdened obstetric history and circulating antiphospholipid antibodies
by: D. R. Eremeeva, et al.
Published: (2024-09-01)

Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
by: E. S. Orlova, et al.
Published: (2025-01-01)

Migraine in antiphospholipid syndrome and hereditary thrombophilia: pregnancy-related clinical and diagnostic features and therapeutic issues
by: O. N. Voskresenskaya, et al.
Published: (2024-11-01)

А clinical case of thrombosis in a teenager in the post COVID-19 period
by: L. V. Zhdanova, et al.
Published: (2023-05-01)

Catastrophic antiphospholipid syndrome. Pathogenesis issues
by: V. O. Bitsadze, et al.
Published: (2016-06-01)

Ischemic stroke in anti-β2-glycoprotein I IgA-associated non-criteria antiphospholipid syndrome: a case report of arterial recanalization via antiplatelet therapy
by: Jihong Liu, et al.
Published: (2025-07-01)

Anti-LGI1 encephalitis and co-existence of MOG-IgG: a case report and literature review
by: Xiaojiao Ci, et al.
Published: (2025-07-01)

Risks of reproductive loss and placenta-mediated pregnancy complications in women with antiphospholipid antibodies
by: Yu. S. Dolgova, et al.
Published: (2021-01-01)

Anticardiolipine antibodies in skin and muscle eluates of patients with primary and secondary antiphospholipid syndrome
by: Z S Alekberova, et al.
Published: (2004-08-01)

Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2023-02-01)

Thromboembolic complications in antiphospholipid syndrome and ankylosing spondylitis (two clinical cases)
by: K. S. Nurbaeva, et al.
Published: (2021-02-01)

Global antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus
by: F. A. Cheldieva, et al.
Published: (2022-11-01)

ANTIPHOSPHOLIPID SYNDROME AND EARLY REPRODUCTIVE FAILURE
by: M. I. Krivonos, et al.
Published: (2017-03-01)